Stroke Prevention in Atrial Fibrillation

2016 ESC Guidelines for the management of atrial fibrillation
Comparison of dabigatran versus warfarin in diabetic patients
Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies
Updated European Heart Rhythm Association Practical Guide

Literature review: stroke prevention in atrial fibrillation

The review includes the pivotal randomised controlled trials for warfarin and direct oral anticoagulants as well as relevant publications from the last 18 months. The following search terms were used: ‘stroke prevention’, ‘atrial fibrillation’, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, ‘oral anticoagulants’, ‘non-VKA oral anticoagulants’, novel oral anticoagulants’, ‘direct oral anticoagulants’, ‘reversal agents’

Videos

Webinars

Key Articles

Independent Medical Education

New This Month

Guidelines/ Expert Recommendations

Randomised Controlled Trials

Meta-Analyses

Real World / Retrospective Studies

Post-Hoc/Subgroup Analysis Of Pivotal Trials - Dabigatran

Post-Hoc/Subgroup Analysis Of Pivotal Trials - Rivaroxaban

Post-Hoc/Subgroup Analysis Of Pivotal Trials - Edoxaban

Post-Hoc/Subgroup Analysis Of Pivotal Trials - Apixaban

Post-Hoc/Subgroup Analysis Of Pivotal Trials - Diabetes

Post-Hoc/Subgroup Analysis Of Pivotal Trials - Elderly

Post-Hoc/Subgroup Analysis Of Pivotal Trials - Hypertension

Post-Hoc/Subgroup Analysis Of Pivotal Trials - Valvular

Other Studies

Reviews/Others

Specific Clinical Indications

Practical Aspects of Use

Reversal Agents

Ablation strategies

Latest articles

Subscribe to Stroke Prevention in Atrial Fibrillation